Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:38:15 EDT Sun 08 Mar 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 14 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-03-08 22:00U:CMENews ReleaseCME Group Announces First Trades for South Asia Crude Palm Oil (Fastmarkets) Futures
2026-03-08 21:55U:TMKEFNews ReleaseTMK Energy Limited Ltd (TMKEF) Gas Rate Surges at Gurvantes XXXV CSG Project
2026-03-08 21:00U:LFSNews ReleaseLEIFRAS Co., Ltd. to Acquire Four Child Development Support and After-School Daycare Facilities in Miyagi Prefecture
2026-03-08 20:00U:FFAINews ReleaseFaraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: Completes Delivery of Master Robot and Pre-Delivery of Aegis Robot to NS Federation in Texas, Expanding Education and Performance Scenarios for EAI Robotics
2026-03-08 19:23U:VENUNews ReleaseVenu Holding Corporation Announces Pricing of $75 million Public Offering
2026-03-08 18:14U:CMULFNews ReleaseIron Bear Resources Limited (CMULF) Quarterly Activities Report
2026-03-08 18:01U:DYNNews ReleaseDyne Therapeutics Announces Initiation of Phase 3 HARMONIA Trial of Z-Basivarsen in Myotonic Dystrophy Type 1 (DM1)
2026-03-08 18:00U:DYNNews ReleaseDyne Therapeutics Announces New Positive Cardiopulmonary Results from DELIVER Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD)
2026-03-08 17:30U:TNews ReleasePascal Desroches to Update Shareholders at Deutsche Bank Media, Internet & Telecom Conference on March 9
2026-03-08 17:30U:TNews ReleasePascal Desroches to Update Shareholders at Deutsche Bank Media, Internet & Telecom Conference on March 9
2026-03-08 17:28U:DYLLFNews ReleaseDeep Yellow Limited (DYLLF) Appoints Jennifer Mintz as Chief Legal Officer
2026-03-08 17:00U:DNTHNews ReleaseDianthus Therapeutics to Host Conference Call and Webcast to Discuss the Interim Responder Analysis Results of the Phase 3 Captivate Trial of Claseprubart in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
2026-03-08 14:00U:XENENews ReleaseXenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026
2026-03-08 13:00U:PSXNews ReleasePhillips 66 Appoints Howard Ungerleider and Kevin Meyers to Board of Directors